Sign Up
Stories
Oncology Drugs Market Surge 2030
Share
Bicycle Therapeutics' Bicycle Toxin Conj...
Biocytogen and Radiance Collaborate on D...
Biosimilar Interleukins Market Growth
Oncology Drugs Market Booms 2030
Oncology Drugs Market Booms by 2030
Oncology Drugs Market Booms in 2030
Overview
API
The global oncology drugs market is set to reach $474.06 billion by 2030 with a strong CAGR of 11.53%. Key drivers include the increasing cancer cases, treatment advancements, and high investments in R&D. Market segmentation involves therapy, drug class, indication, dosage forms, and distribution channels, with targeted therapy and injectables leading the way. North America dominates due to high cancer prevalence and advanced healthcare infrastructure, with major players like AbbVie, Takeda Pharmaceutical, Roche, Pfizer, and Novartis.
Ask a question
How might the increasing number of cancer cases globally impact the demand for oncology drugs?
In what ways could advancements in treatment types further revolutionize the oncology drugs industry?
What role do merger and acquisition deals play in shaping the competitive landscape of the oncology drugs market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2029
Nov 2029
Dec 2029
Coverage
strat